07/12/2017 12:55:55

Big3Bio Introduces Inaugural Sponsors and Partners of BioWeekSF

SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Big3Bio is proud to announce the leading industry organizations that have signed on as inaugural partners and sponsors of BioWeekSF, the site dedicated to the J.P. Morgan Healthcare Conference week in San Francisco, January 7-12, 2018 (“JPM Week”). These organizations will help optimize attendees’ experiences at JPM Week by providing exclusive deals/discounts, premium content, consulting services and more.

BioWeekSF’s partners and sponsors:

  • BIOWelcome Partner: BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

  • TorreyaLaunch Sponsor: Torreya is a leading corporate finance advisory boutique serving companies in the life sciences industry.

  • Charles River LabsPremier Sponsor: Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

  • TriNetPremier Sponsor: TriNet provides industry-tailored HR solutions to small and midsize businesses with exceptional human resources services delivered by an expert team of HR professionals and enabled by cloud-based technology.

  • Venture ValuationPremier Sponsor: Venture Valuation is the life science industry leader in providing independent assessment and valuation of companies, products and patents.

  • California Life Science Association (CLSA) – Gold Sponsor: CLSA advances California’s world-leading life sciences innovation ecosystem by advocating for effective national, state and local public policies and supporting entrepreneurs and life sciences businesses.

  • McDermott Will & EmeryGold Sponsor: McDermott Will & Emery is a premier international law firm with globally recognized practices in healthcare and life sciences; the firm recently won “Healthcare and Life Sciences Deal of the Year.

  • Silicon Valley Bank (SVB)Gold Sponsor: SVB provides financing and banking solutions—including credit and liquidity offerings—that helps healthcare and life science companies hit their milestones, so they can focus on developing their products.

  • Halloran Consulting GroupSupporting Partner: Halloran Consulting Group is a management consulting firm for the life sciences industry providing excellence in regulatory, quality, and clinical development.

  • LaVoieHealthScienceSupporting Partner: LaVoieHealthScience provides IR and PR to build recognition, sales and value for health science innovations.

  • Slone Partners – Supporting Partner: Slone Partners is an executive search firm that specializes in recruitment for the life sciences.

  • Potrero Hill AdvisorsAdvisory Partner: Potrero Hill Advisors provides strategic and financial advisory services for the life sciences.

“We are excited to be a part of the new BioWeekSF platform that will help people maximize their time at the wide variety of networking opportunities and events in San Francisco during J.P. Morgan Healthcare Conference week,” said Krist Werling, Partner at McDermott Will & Emery.  “We’ll be using this new tool to promote the many events that our firm is hosting and participating in that week, and to share knowledge about trends in the industry, allowing us to broaden our reach.  McDermott Will & Emery fuels the mission of life sciences and healthcare companies across the globe, and we look forward to seeing many of our current and future clients make use of this platform to make connections during this important annual industry gathering.”

In addition, BioWeekSF announces two upcoming webinars:

  • On December 12, BioWeekSF will present to its members the Venture Valuation webinar, “Valuation to Raise Money.” In this webinar, CEO Patrick Frei will provide an overview and discuss valuation, financing and raising money, rNPV product valuation, and deal structuring.

  • BIO and BioWeekSF will have a webinar on December 13, “Overview of JPM Week Receptions, Events & Conferences,” discussing the week’s activities, how BIO’s One-on-One Partnering™ system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives, and how BioWeekSF can optimize attendees’ JPM Week experience.

For more information and to become a member of BioWeekSF, visit BioWeekSF.com.

BioWeekSF, BIO, and BIO’s provision of the BIO One-on-One Partnering™ system are not affiliated with J.P. Morgan or the J.P. Morgan Healthcare Conference.

About Big3Bio

Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives. More information and subscriptions are available at www.big3bio.com.


Robert Slocumb


Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
13 Dec
Hvem tør efterhånden investere på børsen, med dette ufatteligt ødelæggende shorting og naked-short v..
10 Dec
Der er simpelhen så meget støj i marked omkring Vestas. Prøv at vurdere disse få tal, og din beslutn..
14 Dec
Faldt lige over denne artikel, som er frigivet 20/11 2017.... Asertaa-studiet med dens konklusioner ..
10 Dec
  @djks Tak for dine altid velovervejede indlæg, som er af stor betydning for debatten, idet man som..
12 Dec
Prøver du at dække dig ind under Bavarian for at undgå at vi snakker om dine enorme tab i Matas og R..
10 Dec
En julehilsen fra alpehue, og  et "Olympic" tillykke til Novo, dens aktionærer og verdens diabetespa..
13 Dec
Han har ingen model. Det er noget han altid skriver. Det er som i SKAT - der mangler ikke folk i Ska..
14 Dec
Citat: »Vores ordreindgang voksede 50 pct. i det seneste kvartal. Der er intet galt med vores salg, ..
12 Dec
Minder lige om denne fra d. 21.11.2017:http://medwatch.dk/Medicinal___Biotek/article10047753.ece   "..
09 Dec
Lad mig prøve vs. Vestas at tage "prispres" fra en anden side, for der er også prispres i USA !!   M..

Form 8.3 - Tesco PLC

14/12/2017 11:47:54
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Jupiter Asset Management (b) Owner or controlle..

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

14/12/2017 10:47:13
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Alliance Trust PLC : Transaction in Own Shares

14/12/2017 07:00:14
14 December 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 13 December 2017 the Company purchased for cancellation 100,000 ordinary shares of 2.5p each at a price of 739.7112p per share.  Therefore, the total number of voting rights in the Company is now 347,776,156.    The above figure (347,776,156) may be used by sha..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Voip-Pal.com, Inc. Discusses the Global Potential of its RBR Parent Patent
Make Christmas Personal with New Celebrity Video Ecards from American Greetings
Impac Mortgage Holdings, Inc. Announces Hire of Rian Furey to lead its Consumer Direct Retail Channel
Kirkland Lake Gold Provides Final Reminder of December 15, 2017 Conversion Deadline to Convertible Debenture Holders
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
15 December 2017 08:12:45
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171124.1 - EUROWEB4 - 2017-12-15 09:12:45 - 2017-12-15 08:12:45 - 1000 - Website: OKAY